NCT02104050

Study of OLT1177 Gel to Treat Moderate to Severe OA Knee Pain

A Phase 2b Randomized, Double-Blind, Vehicle-Controlled, Repeat-Dose, Multi- Center, Efficacy and Safety Clinical Trial of Topically Applied OLT1177 Gel in Subjects With Moderate to Severe Pain Associated With Osteoarthritis of the Knee Following Cessation of Pain Therapy

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 202 (actual)
• Sponsor: Olatec Therapeutics LLC · Industry
• Sex: All
• Age: 45 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

The objectives of this trial are to investigate the efficacy and safety of six weeks of treatment with OLT1177 Gel in subjects with moderate to severe pain associated with osteoarthritis of the knee following cessation of pain therapy.

Conditions

• Osteoarthritis
• Pain

Interventions

Type	Name	Description
DRUG	Placebo Gel	6 mL of Placebo Gel administered TID for 6 weeks
DRUG	OLT1177 Gel	6 mL of OLT1177 Gel (5%) administered TID for 6 weeks

Timeline

• Start date: 2014-04-01
• Primary completion: 2015-08-01
• Completion: 2015-08-01
• First posted: 2014-04-04
• Last updated: 2017-10-06

Locations

13 sites across 1 country: United States